Oulman Roxanne 4
4 · Klaviyo, Inc. · Filed Jun 11, 2026
Research Summary
AI-generated summary of this filing
Klaviyo (KVYO) Director Roxanne Oulman Receives Award, Converts Shares
What Happened
- Roxanne Oulman, a director of Klaviyo, was awarded 14,822 restricted stock units (RSUs) on June 9, 2026 (grant recorded at $0). On June 11, 2026 she converted 8,169 shares of Series B common stock into 8,169 shares of Series A common stock (the filing shows the derivative security disposed at $0 due to conversion). No cash changed hands in these entries.
Key Details
- Transactions and prices:
- 2026-06-09: Award of 14,822 RSUs (listed at $0).
- 2026-06-11: Conversion of 8,169 Series B shares into 8,169 Series A shares (conversion recorded as acquisition of Series A and disposition of the derivative at $0 / N/A value).
- Shares held after transactions (per filing): 22,521 shares of Series A Common Stock and 14,822 unvested RSUs.
- RSU vesting: RSUs vest in full on the earlier of June 9, 2027 or the issuer’s next annual meeting, subject to continued board service.
- Series B conversion terms: Series B shares are convertible into Series A at the holder’s option and may automatically convert on certain events (no expiration date).
- Other holdings/notes: Filing references 46,666 Series B shares previously transferred to the Roxanne Oulman 2025 GRAT; the reporting person disclaims beneficial ownership of those shares except to the extent of any pecuniary interest.
- Filing timeliness: Report filed June 11, 2026 covering transactions on June 9 and June 11 — no late filing indicated.
Context
- These entries are an award (RSUs) and a conversion of a convertible class of stock into common shares, not open‑market buys or sales. The RSUs are contingent and subject to vesting; the Series B conversion is a restructuring of security form rather than a sale for cash. Such conversions and awards are standard insider equity activities and do not by themselves indicate a trading view.
Insider Transaction Report
Form 4
Klaviyo, Inc.KVYO
Oulman Roxanne
Director
Transactions
- Award
Series A Common Stock
[F1]2026-06-09+14,822→ 29,174 total - Conversion
Series A Common Stock
[F2][F3]2026-06-11+8,169→ 37,343 total - Conversion
Series B Common Stock
[F2]2026-06-11−8,169→ 15,165 total→ Series A Common Stock (8,169 underlying)
Holdings
- 46,666(indirect: By Roxanne Oulman 2025 GRAT)
Series B Common Stock
[F2][F4][F5]→ Series A Common Stock (46,666 underlying)
Footnotes (5)
- [F1]Represents restricted stock units ("RSUs") awarded under the Issuer's 2023 Stock Option and Incentive Plan (the "Plan"), each representing the contingent right to receive one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), upon vesting and settlement. The RSUs vest in full upon the earlier of (i) June 9, 2027 or (ii) the date of the Issuer's next annual meeting of stockholders, in each case subject to the Reporting Person's continued service as a member of the Issuer's board of directors through such vesting date.
- [F2]Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of Series A Common Stock of the Issuer, and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date.
- [F3]Consists of (i) 22,521 shares of Series A Common Stock and (ii) 14,822 unvested RSUs awarded under the Plan, each representing the contingent right to receive one share of Series A Common Stock upon vesting and settlement.
- [F4]Reflects 46,666 shares of Series B Common Stock previously transferred from the Reporting Person to Roxanne Oulman 2025 GRAT.
- [F5]Shares held by Roxanne Oulman 2025 GRAT, of which the Reporting Person serves as trustee. The Reporting Person disclaims Section 16 beneficial ownership of such shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that he has beneficial ownership of such shares for Section 16 or any other purpose.
Signature
/s/ Landon Edmond, Attorney-in-Fact|2026-06-11